Abiomed, Inc. operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abiomed with three other companies in this sector in the United States: Angiodynamics, Inc. (2019 sales of $270.63 million of which 44% was Vascular Interventions & Therapies), Haemonetics Corporation ($967.58 million of which 41% was North America Plasma), and Accuray Inc ($418.79 million of which 53% was Service).

Sales Analysis. During the year ended March of 2019, sales at Abiomed were $769.43 million. This is an increase of 29.6% versus 2018, when the company's sales were $593.75 million. This was the fifth consecutive year of sales increases at Abiomed (and since 2014, sales have increased a total of 319%).